Chromium-insulin reduces insulin clearance and enhances insulin signaling by suppressing hepatic insulin-degrading enzyme and proteasome protein expression in KKAy mice

JDS-CRI-003 (CRI) is a novel form of insulin that has been directly conjugated with chromium (Cr) instead of zinc. Our hypothesis was that CRI enhances insulin’s effects by altering insulin degrading enzyme (IDE) and proteasome enzymes. To test this hypothesis, we measured hepatic IDE content and p...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Zhong Q Wang, Yongmei eYu, Xian H Zhang, James eKomorowski
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Frontiers Media S.A. 2014-07-01
Cyfres:	Frontiers in Endocrinology
Pynciau:	Liver insulin signaling Proteasome Chromium-insulin IRS-1 Insulin degrading enzyme
Mynediad Ar-lein:	http://journal.frontiersin.org/Journal/10.3389/fendo.2014.00099/full
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!